ACC.26 Recap: 6 Practice-Changing Trials to Know

The American College of Cardiology (ACC) Scientific Sessions 2026 saw the presentation of a slew of major, practice-changing studies and trials. Between fractional flow reserve (FFR) angiography in patients with coronary artery disease (CAD) from the ALL-RISE trial to mavacamten’s positive efficacy data in adolescent patients with obstructive hypertrophic cardiomyopathy (oHCM), major data was presented for just about every major disease state in cardiology.